Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 66.15% is in line with its 5-year average of 66.90%, around the middle of its 5-year range (55.20%–72.17%).
0.96% below its 12-month average of 66.79%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 72.17%.
GROSS MARGIN
66.15%
GROSS MARGIN AVG TTM
66.79%
GROSS MARGIN AVG 3Y
69.46%
GROSS MARGIN AVG 5Y
66.90%
GROSS MARGIN AVG 10Y
66.25%
GROSS MARGIN AVG 15Y
66.12%
GROSS MARGIN AVG 20Y
65.59%
CURRENT VS TTM AVG
-0.96%
CURRENT VS 3Y AVG
-4.76%
CURRENT VS 5Y AVG
-1.13%
CURRENT VS 10Y AVG
-0.15%
CURRENT VS 15Y AVG
+0.04%
CURRENT VS 20Y AVG
+0.85%
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+60.54%
vs the sector median at left
Alphatec Holdings, Inc.
Market Cap
$1.62B
Gross Margin
66.15%
TTM Avg
66.79%
3Y Avg
69.46%
5Y Avg
66.90%
Market Cap
$1.63B
Gross Margin
51.01%
TTM Avg
55.14%
3Y Avg
57.28%
5Y Avg
56.79%
Market Cap
$1.61B
Gross Margin
87.11%
TTM Avg
89.24%
3Y Avg
90.16%
5Y Avg
89.75%
Market Cap
$1.59B
Gross Margin
53.89%
TTM Avg
45.92%
3Y Avg
-11.61%
5Y Avg
-9.29%
Market Cap
$1.57B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
66.67%
Market Cap
$1.70B
Gross Margin
100.00%
TTM Avg
-1291.39%
3Y Avg
-620.70%
5Y Avg
-620.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.62B | 66.15% | 66.79% | 69.46% | 66.90% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 51.01% | 55.14% | 57.28% | 56.79% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 44.77% | 42.62% | 43.56% | 44.93% |
| Septerna Inc (SEPN)vs › | $1.61B | 99.57% | 100.00% | 75.00% | 75.00% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 87.11% | 89.24% | 90.16% | 89.75% |
| uniQure N.V. (QURE)vs › | $1.60B | 89.53% | 60.98% | 58.20% | 16.96% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 53.89% | 45.92% | -11.61% | -9.29% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 100.00% | 100.00% | 100.00% | 66.67% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | 100.00% | -1291.39% | -620.70% | -620.70% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 97.47% | 96.23% | 48.12% | 65.41% |
Gross Margin
66.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 72.17% |
| 2026-03-31 | 61.08% |
| 2025-12-31 | 61.24% |
| 2025-09-30 | 69.87% |
| 2025-06-30 | 69.58% |
| 2025-03-31 | 68.56% |
| 2024-12-31 | 68.77% |
| 2024-09-30 | 68.16% |
| 2024-06-30 | 70.48% |
| 2024-03-31 | 70.30% |
| 2023-12-31 | 68.99% |
| 2023-09-30 | 67.69% |
| 2023-06-30 | 55.20% |
| 2023-03-31 | 64.54% |
| 2022-12-31 | 64.99% |
| 2022-09-30 | 66.25% |
| 2022-06-30 | 65.92% |
| 2022-03-31 | 69.38% |
| 2021-12-31 | 61.15% |
| 2021-09-30 | 63.00% |
| 2021-06-30 | 65.97% |
| 2021-03-31 | 72.21% |
| 2020-12-31 | 71.42% |
| 2020-09-30 | 71.03% |
| 2020-06-30 | 70.34% |
| 2020-03-31 | 69.84% |
| 2019-12-31 | 68.64% |
| 2019-09-30 | 68.26% |
| 2019-06-30 | 69.13% |
| 2019-03-31 | 67.47% |
| 2018-12-31 | 65.39% |
| 2018-09-30 | 64.84% |
| 2018-06-30 | 64.74% |
| 2018-03-31 | 63.69% |
| 2017-12-31 | 58.19% |
| 2017-09-30 | 62.83% |
| 2017-06-30 | 64.60% |
| 2017-03-31 | 59.97% |
| 2016-12-31 | 53.99% |
| 2016-09-30 | 59.38% |
| 2016-06-30 | 64.62% |
| 2016-03-31 | 69.77% |
| 2015-12-31 | 67.01% |
| 2015-09-30 | 67.08% |
| 2015-06-30 | 59.80% |
| 2015-03-31 | 68.48% |
| 2014-12-31 | 71.04% |
| 2014-09-30 | 72.02% |
| 2014-06-30 | 68.78% |
| 2014-03-31 | 68.61% |
| 2013-12-31 | 67.27% |
| 2013-09-30 | 49.14% |
| 2013-06-30 | 63.74% |
| 2013-03-31 | 65.76% |
| 2012-12-31 | 62.10% |
| 2012-09-30 | 63.27% |
| 2012-06-30 | 62.60% |
| 2012-03-31 | 65.66% |
| 2011-12-31 | 50.32% |
| 2011-09-30 | 63.43% |
| 2011-06-30 | 58.71% |
| 2011-03-31 | 64.26% |
| 2010-12-31 | 66.80% |
| 2010-09-30 | 65.33% |
| 2010-06-30 | 63.48% |
| 2010-03-31 | 62.36% |
| 2009-12-31 | 62.01% |
| 2009-09-30 | 63.69% |
| 2009-06-30 | 64.63% |
| 2009-03-31 | 64.62% |
| 2008-12-31 | 59.24% |
| 2008-09-30 | 64.72% |
| 2008-06-30 | 66.39% |
| 2008-03-31 | 66.00% |
| 2007-12-31 | 59.10% |
| 2007-09-30 | 63.68% |
| 2007-06-30 | 63.68% |
| 2007-03-31 | 64.80% |
| 2006-12-31 | 68.13% |
| 2006-09-30 | 61.94% |
| 2006-06-30 | 66.19% |
| 2006-03-31 | 64.45% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
